Phio Pharmaceutical

-$0.01 (-0.60%) Today
+$0.03 (+1.80%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PHIO and other ETFs, options, and stocks.

About PHIO

Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics that addresses unmet medical needs. Its clinical product candidate includes RXI-109, an RNAi compound developed for the reduction of dermal scarring in planned surgeries.

CEO
Gerrit Dispersyn
Employees
10
Headquarters
Marlborough, Massachusetts
Founded
2011

PHIO Key Statistics

Market Cap
22.60M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
269.47K
High Today
$1.81
Low Today
$1.66
Open Price
$1.66
Volume
493.29K
52 Week High
$4.36
52 Week Low
$1.57

PHIO Earnings

-$1.33
-$0.89
-$0.44
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure